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We have  purified,  to  apparent homogeneity, a mucin 
B6N-acetylglucosaminyltransferase (B6GlcNAc trans- 
ferase)  from  bovine  tracheal  epithelium. Golgi mem- 
branes  were isolated  from a 0.25 M sucrose  homogenate 
of epithelial  scrapings  by  discontinuous  sucrose  gra- 
dient  centrifugation.  The Golgi membranes  were sol- 
ubilized with 1% Triton X-100 in  the  presence of 1 mM 
Gawl-3GalNAcabenzyl (Bzl) to  stabilize  the 
B6GlcNAc transferase. The solubilized enzyme was 
bound to a UDP-hexanolamine-Actigel-ALD Super- 
flow  affinity column equilibrated  with 1 mM GalBl- 
3GalNAcaBzl and 5 mM Mn2+. Elution of the enzyme 
with 0.5 mM UDP-GlcNAc resulted  in a 133,800-fold 
purification  with a 1.3% yield and a specific activity 
of 70 pmollminlmg protein.  Radioiodination of the pu- 
rified  enzyme  followed  by  sodium  dodecyl  sulfate-poly- 
acrylamide gel electrophoresis and autoradiography 
revealed a single  band at 69,000 Da. Kinetic  analyses 
of the B6GlcNAc tranferase-catalyzed  reaction showed 
an  ordered  sequential mechanism in  which  UDP- 
GlcNAc binds  to  the  enzyme first and UDP is released 
last. The K,,, values for UDP-GlcNAc and GalB1- 
3GalNAcaBzl were 0.36 and 0.14 mM, respectively. 
Acceptor  competition studies  showed  that  the  purified 
B6GlcNAc transferase  can  use  core 1 and  core 3 mucin 
oligosaccharides as well as GlcNAcBl-3GalBR as ac- 
ceptor  substrates.  Proton NMR analyses of the  three 
products demonstrated that GlcNAc was added in a 
B1-6 linkage  to  the  penultimate GalNAc or Gal,  sug- 
gesting  that  this  enzyme is capable of synthesizing all 
B6GlcNAc structures  found  in  mucin-type oligosaccha- 
rides. 
The oligosaccharides of glycoproteins play crucial roles in 
many important biological processes such as cell-cell inter- 
action,  differentiation, bacterial and viral adhesion, and  pro- 
tein  stability  and solubility (Olden et al., 1985; Rademacher 
et al., 1988; Paulson, 1989). In addition, they  are the major 
constituents of airway mucins and  contribute to  the rheolog- 
ical properties of mucus gels that protect epithelia (Hill et al. 
1977; Boat  and Cheng, 1980). 
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Mucin carbohydrate structures are extremely heteroge- 
neous. The number of different oligosaccharides of respiratory 
tract mucins from one individual can exceed 100 (Roussel, 
1985), and their sizes vary from 1 to more than 20 sugar 
residues per chain. Although most mucins contain the five 
sugars GalNAc, Gal, GlcNAc,  Fuc,’ and sialic acid, oligosac- 
charide chains without GlcNAc are limited in size to  penta- 
saccharides, such as  the sialylated oligosaccharides that ex- 
hibit blood group A activity found in porcine submaxillary 
mucins (Carlson, 1968). Thus, GlcNAc transferases, which 
synthesize these N-acetylglucosaminides, play key roles in the 
elongation of mucin-type oligosaccharides.  Among these 
GlcNAc transferases, only the PGGlcNAc transferases are 
responsible for the synthesis of branched mucin-type oligo- 
saccharides (Fukuda et al., 1986). In addition, recent data 
implicate the mucin core 2 P6GlcNAc transferase  as  a differ- 
entiation marker of human lymphoid cells (Fukuda, 1989). 
Elevation of this enzyme activity has also been associated 
with malignant transformation (Yousefi et al., 1991) and 
Wiskott-Aldrich Syndrome (Higgens et al., 1991). 
PGGlcNAc transferase activity from a variety of tissues has 
been described (Williams and Schachter, 1980; Williams et 
al., 1980; Wingert and Cheng, 1984; Cheng et al., 1985; Brock- 
hausen et al., 1985; Brockhausen et al., 1986; Koenderman et 
al., 1987; Koenderman et al., 1989; Sekine et al., 1990; San- 
gadala et d., 1991).  However, the extreme instability of this 
enzyme following its solubilization from membranes has ham- 
pered its purification. Our report describes, for the first time, 
the purification of a mucin PGGlcNAc transferase from  bovine 
tracheal epithelium to apparent homogeneity. Kinetic anal- 
yses of the purified enzyme  suggest that  the reaction proceeds 
by an ordered sequential mechanism in  which UDP-GlcNAc 
binds first  and  UDP leaves last. Acceptor competition studies 
demonstrate that  the purified enzyme can form all three of 
the B6GlcNAc branch  structures found in mucin-type oligo- 
saccharides: Galpl-3(GlcNAcpl-6)GalNAcaR, GlcNAcPl- 
3(GlcNAc/31-6)GalNAc~R, and GlcNAc~19(GlcNAc~l- 
6)GalBR. 
EXPERIMENTAL PROCEDURES’ 
The abbreviations used are: Fuc, fucose;  HexNAc, N-acetylhexo- 
samine; PNP, p-nitrophenyl; Bzl, benzyl; Me, methyl; SDS-PAGE, 
sodium dodecyl sulfate-polyacrylamide electrophoresis; MOPS, 3-(N- 
morpho1ino)propanesulfonic acid MES, 2-(N-morpholino)ethane- 
sulfonic acid PMSF, phenylmethylsulfonyl fluoride; CHAPS, 3-[(3- 
cholamidopropyl)dimethylammonio]-l-propanesulfonate; CHAPSO, 
3-[(3-cholamidopropyI)dimethylammonio]-2-hydroxy-l-propanesul- 
fonate; FPDG, freezing point depression glycoprotein. 
Portions of this paper (including “Experimental Procedures,” part 
of “Results,” Figs. 1 and 5-11, and Tables 111 and IV) are presented 
in miniprint at  the end of this paper. Miniprint is easily read with 
the aid of a standard magnifying glass. Full size photocopies are 
included in the microfilm edition of the Journal that is available from 
Waverly Press. 
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TABLE I 
Effect of Gala1 -3GalNAcaBzl  on  the binding of PGGlcNAc transferase 
to UDP-hexanohmine Sephurose 4B 
Columns (4 ml) of UDP-hexanolamine  Sepharose 4B were equili- 
brated with 25 mM Tris-HC1 (pH 7.5), 0.25 M sucrose, and 0.1% 
Triton X-100 with and without 1 mM Gal@1-3GalNAcaBzl. Micro- 
somal membranes were solubilized with 2% Triton X-100 & 1 mM 
Galpl-3GalNAcaBz1,  and 1 ml of the 100,000 X g supernatant was 
applied to the column. The  columns were eluted  with 5 mM UMP f 
1 mM Gal@1-3GalNAcaBzl. 
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Solubilization of P6GkNAc Transferase from the Golgi 
Membranes 
Detergents Effects-A number of detergents were examined 
for their effect on 06GlcNAc transferase activity as well as 
their ability to solubilize the enzyme from Golgi membranes. 
Sucrose mono fatty acid esters of palmitate, stearate, and 
oleate at concentrations up to 2.5% (w/v) were ineffective at 
solubilizing the enzyme activity from these membranes. On 
the other hand, by treating Golgi membranes with 1-5% 
sucrose laurate, n-dodecyl-fi-D-maltoside, or  Triton X-100, we 
recovered  16-26% of the enzyme activity in the soluble form. 
Triton X-100 was selected as  the solubilizing detergent for all 
subsequent studies. 
Stabilization of Enzyme Activity-To improve the yield of 
the solubilized P6GlcNAc transferase, numerous osmolytes 
(Ambudkar and Maloney, 1986) and other agents were ex- 
amined for their ability to stabilize the enzyme during solu- 
bilization with 1% Triton X-100. The most effective stabilizer 
of the enzyme activity was the synthetic acceptor substrate, 
Galpl-3GalNAcaBzl. At concentrations >1 mM during the 
membrane solubilization step, Galpl-3GalNAcaBzl increased 
the yield of solubilized enzyme from about 21% to approxi- 
mately 47%. 
Purification of B6GlcNAc Transferase 
Optimizing Binding Conditions-The binding of  B6GlcNAc 
transferase to  the UDP-hexanolamine affinity columns and 
its recovery depended on the presence of Mn2+  and  the syn- 
thetic acceptor Galfll-3GalNAcaBzl. As indicated in  Table I, 
the acceptor did not significantly affect the distribution of the 
enzyme eluted from the column (void  volume uersw bound). 
However, when the acceptor was included in  the equilibration 
buffer, there was a 2-fold increase in the total amount of 
enzyme bound to and recovered from the column. Inclusion 
of the acceptor in  the elution buffer had  little effect on the 
recovery of enzyme activity. Fig. 2 shows the effect of varying 
Mn2+  concentrations on the binding of P6GlcNAc transferase 
to  the UDP-hexanolamine column. Inclusion of 5 mM Mn2+ 
in the column equilibration buffer resulted in a 2-fold increase 
in the amount of enzyme bound to  the gel.  Above 5 mM Mn2+, 
the amount of enzyme bound to  the affinity gel decreased. 
Affinity Chromatography-UDP-hexanolamine was cou- 
pled to several matrices: cyanogen bromide-activated Sepha- 
rose  4B, tresyl-activated silica, and monoaldehyde-activated 
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[Mn2+1 (mM1 
FIG. 2. Effect of Mn2+ on the binding of 86GlcNAc transfer- 
ase to UDP-hexanolamine Sepharose CL-4B. Golgi membranes 
were treated with 1% Triton X-100 in the presence of 1 mM Gal(31- 
3GalNAcaBzl.  The Mn2+ concentration of the buffer was adjusted  to 
2-11 mM, and 0.2-ml aliquots were applied to 100 mg of UDP- 
hexanolamine  Sepharose CL-4B that had been equilibrated  with 25 
mM MOPS, 0.25 M sucrose, 0.1% Triton X-100, 0.7 mM Galfi1- 
BGalNAcaBzl,  and Mn2+. The mixtures were  incubated at 4 “C for  30 
min with gentle agitation. The gel was washed three  times  (0.2 ml 
each time) with the equilibration  buffer.  The  86GlcNAc  transferase 
reaction  assay  mixture (0.1 ml) was then added directly to the gel 
and the mixture  incubated at 37 “C for 2 h. Products were isolated by 
C18  solid  phase extraction. 
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FIG. 3. Purification of 86GlcNAc transferase on UDP-hex- 
anolamine-Actigel-ALD Superflow using 0.6 mM UDP- 
GlcNAc as the eluent. 06GlcNAc transferase was solubilized in 1% 
Triton X-100 containing 1 mM GalPBGalNAcaBzl  and 5 mM MnC12 
and  applied to a column that had been  equilibrated  with the same 
solution  containing 0.1% Triton X-100.  Elution with 0.5 mM UDP- 
GlcNAc was started at fraction  16,  and  0.5 M NaCl elution  was started 
at fraction 36. 
agarose (Actigel-ALD Superflow). The ligand densities ob- 
tained on these matricies were 2-4, 10, and 20 pmol/ml, 
respectively. Recoveries of enzyme activities from these col- 
umns were 30, 15, and 80%, respectively. Because UDP- 
hexanolamine-Actigel-ALD Superflow column yielded higher 
recovery of enzyme activity, it was chosen for the purification 
of the B6GlcNAc transferase. 
Purification Protocol-Golgi membranes were solubilized 
(as described under “Experimental Procedures”) and applied 
to a 5-ml UDP-hexanolamine-Actigel-ALD Superflow column 
that had been equilibrated with 1 mM GalB1-3GalNAcaBzl. 
Approximately 50% of the enzyme activity was  recovered in 
the void volume of the column. Upon reapplication of this 
material to a fresh affinity column, no further binding was 
observed (data  not shown) suggesting that  the column was 
not overloaded. UDP-GlcNAc (0.5 mM) eluted approximately 
50% of the bound P6GlcNAc transferase activity (Fig. 3). The 
purification after  this  step was  133,800-fold with a yield of 
1.3% and  a specific activity of  70 pmol/min/mg protein  (Table 
11). The remainder of the bound enzyme activity was  recovered 
with 0.5 M NaCl (Fig. 3). The 0.5 M NaCl eluted material 
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TABLE I1 
Purification  of bovine tracheal fl6GlcNAc transferase 
step Total protein Total enzyme Specific activity activity Yield Purification 
w units" unitslmg 5% -fold 
BTEb 4588.3' 2.40 0.00052 100.0 1.0 
Sucrose gradient 114.4' 0.41 0.00358 17.1 6.9 
UDP-hexanolamine 0.00046d 0.032 69.6 1.3 133,846.0 
' One unit equals 1 pmol of ["CIGlcNAc  transferred to Galj31-3GalNAc~uBzl  per min. 
Bovine tracheal epithelium homogenate. 
Determined bv a modified  Bradford method as described  under  "Experimental  Procedures." 
Estimated by"radioiodination. 
(KDa) 
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FIG. 4. SDS-PAGE of 1261-labeled B6GlcNAc transferase 
purified on UDP-hexanolamine-Actigel-ALD Superflow 
using 0.5 mM UDP-GlcNAc as the eluent. The purified  B6GlcNAc 
transferase (200 11) was  radioiodinated,  quenched with cytochrome c 
and tyrosine, isolated in the void volume of SpectraGel AcA 202, 
analyzed by SDS-PAGE and autoradiography. The lanes contained 
( a )  solubilized Golgi proteins, (b) blank control, (c) purified enzyme, 
and ( d )  a densitometer scan of lane c. (cyto. c)? represents cytochrome 
c dimer. 
contains at least 7 protein  bands  on  SDS-PAGE  (data not 
shown) and was not characterized further. 
Characterization of the Purified BGGlcNAc Transferase 
SDS-PAGE Analysis-Radioiodination of the material 
eluted with 0.5 mM UDP-GlcNAc followed by SDS-PAGE 
and autoradiography revealed a single band of approximately 
69,000 Da (Fig. 4). 
Acceptor  Competition-The material eluted from the UDP- 
hexanolamine-Actigel-ALD Superflow column with 0.5 mM 
UDP-GlcNAc was examined for other GlcNAc transferase 
activities, in  particular mucin core 4 PGGlcNAc transferase, 
mucin core 3 j33GlcNAc transferase, I antigen (GlcNAcB3 
(GlcNAcS6)Gal) 86GlcNAc transferase, and i antigen (Glc- 
NAcj33Gal)  P3GlcNAc transferase. Only the mucin core 4 and 
I antigen P6GlcNAc transferase activities were detected (data 
not shown). The disposition of the mucin core 4 and I antigen 
P6GlcNAc transferase activities in relation to  the mucin core 
2 p6GlcNAc transferase activity on  the UDP-hexanolamine- 
Actigel-ALD Superflow was examined. As shown in Fig. 12, 
all of these activities coeluted and  the ratio of the enzyme 
activities between the two eluted peaks were essentially iden- 
tical for all  three acceptors, providing evidence that enzyme 
eluted with 0.5 M NaCl is identical to  that eluted with this 
substrate. 
To examine if the observed enzyme activities were exhibited 
by one enzyme or several enzymes, acceptor competition 
studies were carried out using the purified enzyme and pairs 
of the three acceptors: Galj31-BGalNAcaBzl, GlcNAc@l- 
BGalNAcaPNP, and GlcNAcS1-3Gal/3Me. The results are 
Fraction Number 
FIG. 12. Disposition of B6GlcNAc transferase  activities on 
UDP-hexanolamine-Actigel-ALD Superflow. Golgi  membranes 
were solubilized  and the column run as described  under  "Experimen- 
tal Procedures." The enzyme was eluted with 0.5 mM UDP-GlcNAc 
starting at fraction 24 and then with 0.5 M NaCl at fraction 34. 
Fractions 25-40 were assayed for  B6GlcNAc  transferase activity with 
the following acceptors: Galfll-3GalNAcaBzl (0-01, GlcNAcfll- 
3GalNAcaPNP (B- - 4), and  GlcNAcB1-3GalflMe (0.. O). 
summarized in Table V. The observed velocities paralleled 
the theoretical values calculated for one enzyme acting on all 
three  substrates. 
Product Identification-The reaction products of  j36GlcNAc 
transferase with the  three acceptor substrates GalS1- 
3GalNAcaBz1, GlcNAc/31-3GalNAcaPNP, and GlcNAcBl- 
3GalbMe  were isolated and analyzed by 'H-NMR  as described 
under "Experimental Procedures." As shown in Table VI, the 
coupling constant for the newly formed P6GlcNAc structures 
was 8.5 Hz indicating attachment through a &linkage.  Com- 
parison of the chemical shifts  and coupling constants obtained 
for the  three products with published data for  mucin  core 2, 
Gal~l-3(GlcNAc@l-6)GalNAc-ol (Van Halbeek et al., 1982), 
mucin core 4, GlcNAc~1-3(GlcNAc~1-6)GalNAc-ol (Brock- 
hausen et al., 19851, and GlcNAc@l-3(GlcNAc~1-6)Gal (Van 
Halbeek et al. 1982) indicate that  the P6GlcNAc transferase 
catalyzes the transfer of GlcNAc in a @l-6 linkage to the 
penultimate GalNAc or Gal of the acceptor substrates. This 
enzyme, therefore, is capable of synthesizing all these 
/36GlcNAc structures found in mucin-type oligosaccharides. 
DISCUSSION 
Mucin oligosaccharide chains  are assembled in a sequential 
manner, catalyzed by glycosyltransferases; the product of one 
enzyme reaction serves as  the acceptor for subsequent reac- 
tion. The length and complexity of mucin oligosaccharide 
chains  can be regulated by the relative activities of the chain- 
elongation and -termination glycosyltransferases, both of 
which act  on  the same acceptor sites (Wingert and Cheng, 
1984). As demonstrated by Piller et al. (1988), an increase in 
B6GlcNAc transferase activity and a decrease in a2,6NeuAc 
transferase activity, which accompany activation of T-lym- 
phocytes, shift the major sialylated oligosaccharides  in a cell 
surface glycoprotein from tetra-  to hexasaccharides. Elevation 
of P6GlcNAc transferase activity also has been reported in 
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TABLE V
Acceptor  competition studies of purified B6GlcNAc transferase 
Acceptoro concentration 
A B C 
U o h b  
u,.lC  u,.le Conclu- 
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13.3 19.8 1E 
15.7 ~ ~. 1.50 1.50 14.7 23.8 
The acceDtors  were (A) GalB1-3GalNAcaBzl. (B1 GlcNAcBl- 
3GalNAcaPNP, and (C) GlcNAc~1-3Gal/3Me. 
* Velocities are expressed as nanomoles/h/ml and were determined 
by the anion exchange assay system. 
Velocities for one enzyme acting on both substrates were calcu- 
lated by u = [ Vl(Sl/K,) + Vz(Sz/Kz)]/[l + SJK, + S2/Kz ] ,  where V, 
S,  and K are the maximal velocity, substrate concentration, and the 
Michaelis constant, respectively, for substrates 1 and 2. The maximal 
velocities for  A, B, and C were 17.2, 20.0, and 9.0 pmol/min, respec- 
tively. The Michaelis constants for A, B, and C were 0.07,  0.26, and 
0.53 mM, respectively. 
Calculated velocity, u = u1 + uz, for a two-enzyme system where 
u1 and uz are the observed velocities for each substrate alone. 
, . ,  
leukemic cells (Brockhausen et al., 1991;  Yousefi et al., 1991) 
and in T-cells and  platelets of patients with Wiskott-Aldrich 
Syndrome who are a t  risk for malignant transformation of 
hematopoietic cells (Higgins et al., 1991). In addition, this 
enzyme activity is enriched in tracheal goblet There- 
fore, this 06GlcNAc transferase may play important roles in 
the normal functions of lymphocytes and their metastatic 
processes as well as  the differentiation of airways secretory 
cells. 
The UDP-GlcNAc:Galp1-3GalNAc (GlcNAc to GalNAc) 
p6GlcNAc transferase first was described by Williams and 
Schachter (1980) in canine submaxillary glands. Since then, 
this enzyme has been reported in a number of other  tissues 
(Wingert and Cheng, 1984; Brockhausen et al., 1985; Cheng 
et al., 1985; Yazawa et dl., 1986; Brockhausen et al., 1986; 
Koenderman et al., 1987; Fukuda, 1989; Greer et al., 1989; 
Koenderman et al., 1989; Sekine et al., 1990; Sangadala et al., 
1991). To better  understand the role of this transferase in the 
control of mucin-type oligosaccharide biosynthesis, we under- 
took the purification of the B6GlcNAc transferase from bovine 
tracheal epithelium. This tissue was chosen because of its 
high P6GlcNAc transferase activity and  its  apparent absence 
of UDP-GlcNAc:Galpl-3GalNAc (GlcNAc to Gal) p3GlcNAc 
transferase activity (Cheng et al., 1985). 
A number of protein isolation procedures (ie. ion exchange 
P. W. Cheng, unpublished observation. 
chromatography, chromatofocusing, isoelectric focusing,  dye 
affinity chromatography, immobilized metal affinity chro- 
matography, phase separation, precipitation, lectin affinity 
chromatography) were examined as potentially useful steps 
in the purification of P6GlcNAc transferase. All of these 
procedures resulted in extensive losses of enzyme activity and 
little or no enzyme purification. Substrate-  and product-based 
affinity columns were also tested for their purification poten- 
tial. Affinity columns based on the acceptor substrate were 
prepared by coupling freezing point depression glycoprotein 
before and after elastase treatment to cyanogen bromide- 
activated Sepharose 4B or by immobilizing Galpl-3Gal- 
NAcaBzl on C18 silica. These methods were ineffective in 
binding the enzyme,  even in the presence of UDP. Affinity 
columns based on the donor substrate, UDP-GlcNAc, and  its 
analogs were effective in the binding and purification of 
B6GlcNAc transferase.  These affinity columns included Hg- 
UDP-GlcNAc and  Hg-UTP thiopropyl-Sepharose, UDP- 
GlcN  Actigel-ALD Superflow, and UDP-hexanolamine type 
affinity resins. Although all of these affinity columns work 
equally well, the instability of mercuriated nucleotides and 
the cost of synthesizing UDP-GlcN (Ropp and Cheng, 1990) 
have limited the usefulness of these ligands. Our purification 
of 86GlcNAc transferase therefore was based on the use of 
UDP-hexanolamine affinity gels. 
We devised a rapid two-step purification procedure that 
resulted in a 133,800-fold purification of the p6GlcNAc trans- 
ferase with a specific activity of  70 pmol/min/mg protein  and 
an overall yield of 1.3%. After radioiodination, SDS-PAGE, 
and autoradiographic analysis of the 0.5 mM UDP-GlcNAc, 
eluted material showed a single band at approximately 69,000 
Da. Key factors in the purification of the P6GlcNAc transfer- 
ase include 1) the stabilization of enzyme activity with GalP1- 
3GalNAcaBzl during  Triton X-100 solubilization and subse- 
quent binding to  the affinity column and 2) the elution of the 
enzyme from the affinity column with 0.5 mM UDP-GlcNAc. 
However, the instability of the enzyme has thwarted our 
attempts  to scale up the purification procedure and made it 
necessary to purify the enzyme on the day of study. 
Instability of the P6GlcNAc transferase  has also been noted 
in  other  tissues (Brockhausen et al., 1986; Koenderman et al., 
1987; Sekine et al., 1990) but  not for enzyme prepared from 
porcine tracheal epithelium (Sangadala et al., 1991). The 
reported stability of the porcine enzyme, which has been 
partially purified to a final specific activity of  2.4 pmol/min/ 
mg protein, allowed for the use of conventional chromatog- 
raphy and  other time-consuming steps that were not possible 
with the bovine tracheal enzyme. There are several other 
notable differences in the properties of the porcine and bovine 
66GlcNAc transferases. For example, the porcine but  not  the 
bovine enzyme binds to acceptor-type affinity columns. In 
addition, the estimated size of the porcine enzyme,  60,000 Da, 
is somewhat smaller than  the bovine enzyme. We have no 
explanation for these apparent differences in enzyme prop- 
erties. 
Kinetic analyses of the enzyme  revealed that  the enzyme- 
catalyzed reaction proceeds by an ordered sequential mecha- 
nism where UDP-GlcNAc binds first  and  UDP leaves last. 
This type of mechanism has been described for GlcNAc 
transferases I and I1 that  are involved in  the synthesis of N-  
linked oligosaccharides (Nishikawa et al., 1988; Bendiak and 
Schachter, 1987). The Michaelis constants of the purified 
enzyme for UDP-GlcNAc and Galpl-3GalNAccuBzl are 0.36 
and 0.14 mM, respectively. A decrease in  the K ,  for UDP- 
GlcNAc  was observed with increasing purity of the enzyme. 
This may have been due to the removal of enzymes that 
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TABLE VI 
Proton NMR data of  BGlcNAc transferase products using Galpl-3GalNAcaBz1, GlcNAc~l-3GalNAcaBz1, and 
GlcNAcpl-3GalpMe as the acceptors 
Chemical shifts (coupling constants)" 
Residue Proton GlcNAcj31-6  GlcNAcj31-6 GlcNAcj31-6 
Galj3l-3GalNAcaBenzyl GlcNAcj31-3GalNAcaPNP GlcNAc/31-3Galj3Me 
GlcNAcp6 H1 4.538 (8.5) 4.456 (8.4) 
NAc 
4.542 (8.5) 
1.967 2.035 2.034 
GlcNAc03 H l  NDb 4.649 (8.4) 4.690 (8.4) 
NAc ND 2.035 2.034 
GalNAca H1 4.968 (3.8) 5.756 (3.7) ND 
H2 4.308 4.485 ND 
H3 4.067 4.236 ND 
H4 4.224 4.290 ND 
H5 4.149 4.172 ND 
H6 4.015 4.015 ND 
NAc 1.962 2.029 ND 
H4 3.895 ND 4.118 
Gal0 H1 4.425 (7.8) ND 4.282 (8.0) 
Benzyl CH, 4.701, 4.491 ND 
OCHa ND  ND 3.550 
a Chemical shifts are given in parts/million, and the coupling constants shown in parentheses are given in Hertz. 
ND, not determined. 
compete with the P6GlcNAc transferase for UDP-GlcNAc. 
Alternatively, increased stability of the UDP-GlcNAc may 
have been achieved by removal of pyrophosphatases. The K, 
for Galpl-3GalNAcaBzl remained virtually unchanged 
throughout the purification. Although the concentration of 
UDP-GlcNAc in tracheal epithelial cells has  not been deter- 
mined, its  concentration in small intestinal cells is approxi- 
mately 0.5 mM (Zhivkov et al., 1975). The intracellular con- 
centration of UDP-HexNAc in confluent cultures of human 
colon cancer cells varies from 0.15 mM in differentiated cells 
to 5.85 mM in  undifferentiated cells (Wice et al., 1985). Be- 
cause the K,,, of bovine tracheal P6GlcNAc transferase for 
UDP-GlcNAc falls in this concentration range, activity of 
this transferase is likely to be regulated by altering the phys- 
iological concentration of UDP-GlcNAc. 
Substrate competition analyses with the purified enzyme 
revealed that the p6GlcNAc transferase can utilize three 
different mucin-type acceptors: Galpl-BGalNAcaR, GlcNA- 
c@l-3GalNAcaR, and GlcNAcpl-3GalpR. However, it ap- 
pears that  the core 1 structure is a preferred acceptor ( K ,  = 
0.07-0.14  mM) when compared to core 3 ( K ,  = 0.26 mM) and 
i ( K ,  = 0.53 mM) structures. Proton NMR analyses of the 
three  products confirmed that they all contained  a GlcNAc 
residue linked pl-6 to  the penultimate GalNAc or Gal, dem- 
onstrating  that they  are core 2, core 4, and  I  antigen  struc- 
tures, respectively. This relaxed substrate specificity has also 
been observed with the crude enzyme from pig gastric mucosa 
(Brockhausen et al., 1985, 1986), Novikoff ascites tumor cells 
(Koenderman et al., 1987), and  human ovarian tissue (Yazawa 
et al., 1986). Although the P6GlcNAc transferase described in 
this  report  can form all the P6-branched GlcNAc structures 
found in mucin-type oligosaccharides, our observation does 
not preclude the possibility that other B6GlcNAc transferases 
also are involved in the formation of p6-linked GlcNAc struc- 
tures. Brockhausen et al. (1991) has reported that leukocytes 
from normal and leukemic individuals contain the core 2 
P6GlcNAc transferase activity but no core 4 or I antigen 
P6GlcNAc transferase activity, suggesting that  the PGGlcNAc 
transferase from this tissue is specific for the core 1 acceptor. 
The observed acceptor substrate differences between the 
PGGlcNAc transferase from leukocytes and those from the 
other  tissues may  be due to differential expression of isomeric 
forms of the enzyme. Employment of highly purified 
06GlcNAc transferase from leukocytes may be needed to 
clarify the apparent differences in acceptor specificity. 
The porcine enzyme was also examined for its ability to 
form the I  antigen  structure,  but no activity was  observed. It 
is surprising that  the two acceptors, GlcNAcPl-3Galpl- 
3GlcNAc/3l-3Gal(Gal~l-4GlcNAc~1-6)GalNAcol and Glc- 
NAc~1-3Gal~1-3(Gal~l-4GlcNAc/3l-6)GalNAcol, b th of 
which contain the GlcNAcpl-3Gal@-R acceptor structure 
were poor substrates for this enzyme (Sangadala et al., 1991). 
It is possible that  the presence of the Dl-linked Gal  on the 
P6-linked branch is responsible for changing the acceptor 
potential, because acceptors without this Gal residue can serve 
as  substrates for P6GlcNAc transferase from  pig gastric mu- 
cosa (Brockhausen et d., 1986) and Novikoff ascites tumor 
cells (Koenderman et al., 1987). These results suggest that 
the P6GlcNAc transferase must act on the p3-linked Gal prior 
to  the formation of P4Gal structure linked to  the PGGlcNAc. 
There have been several reports of an enzyme capable of 
transferring GlcNAc  in a  pl-6 linkage to terminal galactose 
residues (Zielenski and Koscielak, 1983a, 198313; Van den 
Eijnden et al., 1983; Basu and Basu, 1984;  Yazawa et al., 1986; 
Koenderman et al., 1987). This enzyme activity was not 
detected in any of our preparations. There have also been 
reports of a transferase that transfers GlcNAc in a Pl-6 
linkage to an  internal galactose residue of a polylactosamine 
chain  (Leppanen et al., 1989; Taniguchi et al., 1991). Brock- 
hausen et al. (1986) has shown, with crude P6GlcNAc trans- 
ferase, that when GlcNAc/3l-3Gal~l-3GalNAcaBzl was  used 
as  an acceptor the GlcNAc  was transferred to  the penultimate 
Gal, not to  the internal GalNAc.  We  do not yet  know if the 
bovine PGGlcNAc transferase  has  these activities. Studies are 
needed to further define the acceptor specificity of this  en- 
zyme and  the roles of this  and  other PGGlcNAc transferases 
in the regulation of mucin-type oligosaccharide structures. 
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